Regranex May Increase Cancer Danger in as Little as 3 Treatments

In this study, among those who were prescribed Regranex three or more times, there was an increase in the number of patients who died as a result of cancer. There was not enough information to say whether there was an increase in the number of patients that developed new cancers.

Transvaginal Mesh Problems

Transvaginal Mesh

Transvaginal mesh has become a symbol for all that is wrong with the current system for evaluating medical technology. The product was never thoroughly evaluated for use in pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Because of lax … Continued

Pradaxa is Getting More Competition

In a recent post, I discussed the drug Xarelto (chemically known as rivaroxaban) and the competition this product is running to Boehringer-Ingelheim’s (BI) flagship product, Pradaxa (dabigatran). The introduction of Xarelto in the U.K., a product produced by Bayer and … Continued